Does ABROCITINIB Cause Dermatitis atopic? 110 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 110 reports of Dermatitis atopic have been filed in association with ABROCITINIB (CIBINQO). This represents 3.5% of all adverse event reports for ABROCITINIB.
110
Reports of Dermatitis atopic with ABROCITINIB
3.5%
of all ABROCITINIB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Dermatitis atopic From ABROCITINIB?
Of the 110 reports, 6 (5.5%) required hospitalization.
Is Dermatitis atopic Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABROCITINIB. However, 110 reports have been filed with the FAERS database.
What Other Side Effects Does ABROCITINIB Cause?
Drug ineffective (398)
Condition aggravated (316)
Off label use (269)
Therapeutic product effect incomplete (186)
Pruritus (171)
Rash (134)
Nausea (130)
Headache (85)
Acne (73)
Fatigue (70)
What Other Drugs Cause Dermatitis atopic?
DUPILUMAB (33,670)
TRALOKINUMAB-LDRM (613)
UPADACITINIB (525)
RUXOLITINIB (211)
TACROLIMUS (200)
CRISABOROLE (134)
NEMOLIZUMAB-ILTO (117)
OMALIZUMAB (111)
PREDNISONE (105)
ADALIMUMAB (103)
Which ABROCITINIB Alternatives Have Lower Dermatitis atopic Risk?
ABROCITINIB vs ACALABRUTINIB
ABROCITINIB vs ACAMPROSATE
ABROCITINIB vs ACARBOSE
ABROCITINIB vs ACCUTANE
ABROCITINIB vs ACEBUTOLOL